Siloam Hospitals | Investor Relations - Shareholder Meeting - Rumah Sakit Siloam Hospitals

(1)

Provider of The Year

Frost and Sullivan

Public Expose

(2)

2

Disclaimer

This presentation has been prepared by PT Siloam International Hospitals, Tbk (SILO ) and is circulated for the purpose of general

information only. It is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of SILO. No warranty ( expressed or implied ) is made to the accuracy or completeness of the information. All opinions and estimations included in this report constitute our judgment as of this date and are subject to change without prior notice. SILO disclaims any

responsibility or liability whatsoever arising which may be brought against or suffered by any person as a result of reliance upon the whole or any part of the contents of this presentation and neither SILO nor any of its affiliated companies and their respective employees and agents accept liability for any errors, omission, negligent or otherwise, in this presentation and any inaccuracy herein or omission here from which might otherwise arise.

Forward – Looking Statements

The information communicated in this presentation contains certain statements that are or may be forward looking. These statements

t pi all o tai ords su h as ill , e pe ts a d a ti ipates a d ords of si ilar i port. B their ature, for ard looking statements involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in this presentation. Factors that could cause actual results to differ include, but are not limited to, economic, social, and political conditions in Indonesia ; the state of the property industry in Indonesia; prevailing market conditions; increases in regulatory burdens in Indonesia, including environmental regulation and compliance cost; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and capital availability; the anticipated demand and selling prices for SILO developments and related capital expenditures and investments; the cost of construction; availability of real estate property; competition from other companies and venues; shifts in customer demands; changes in operation expenses, including employee wages, benefits, and training, governmental and public policy

ha ges; “ILO’s a ilit to e a d re ai o petiti e; “ILO’s fi a ial o ditio , usi ess strateg as ell as the pla s a d objectives of

“ILO’s a age e t for future operatio s; ge eratio of future re ei a les; a d e iro e tal o plia e a d re ediatio . “hould one or more of these uncertainties or risks, among others, materialize, actual results may vary materially from those estimated, anticipated or projected. Specifically, but without limitation, capital costs could increase, projects could be delayed and anticipated improvements in production, capacity or performance might not be fully realized. Although SILO believes that the expectations of its management as reflected by such forward –looking statements are reasonable based on information currently available to us, no assurances can be given that such expectations will prove to have been correct. You should not unduly rely on such statements. In any event, these statements speak only as of the date hereof, and SILO undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

(3)

Where We Are In Lippo Karawaci

04 Highly Experienced & Professional Management

05 The Vision

06 The Journey

07 The Operations

08 A Day At Siloam

09 Premier Private Hospital Group

10 –

16 Hospitals Under Development

17 –

24

(4)

4

Where We Are In Lippo Karawaci

Public Expose

As of 31 Dec 2015

No. of Outstanding Shares : 23,077,689,619 Code : LPKR.JK ; LPKR IJ

LIPPO RELATED COMPANIES

26.91%

DEVELOPMENT REVENUE

RECURRING REVENUE

HOSPITALS

COMMERCIAL

ASSET

MANAGEMENT

• Siloam Hospitals

70.8%

• Retail Malls

• Aryaduta

Services, Leisure

and Restaurants

PUBLIC

73.09%

TOWNSHIPS INDUSTRIAL

(5)

dr. Niel Nielson

Independent Commissioner

Highly Experienced & Professional Management

Board of Directors

Romeo Lledo

President Director, Independent Director

dr. Andry

Director

dr. Anang Prayudi Director

Prof. George Mathew

Director

dr. Grace Frelita

Director

Kailas N. Raina

Director

Board of Commissioners

Lee Heok Seng

President Commissioner

Theo L. Sambuaga

Commissioner

Ir. Jonathan L. Parapak

Farid Harianto

Budi Legowo

Director

Jenny Kuistono

Commissioner

Caroline Riady

Director

Norita Alex

(6)

6

The Vision

Public Expose

Reach

Scale

International

Quality

Affordable and Accessible Healthcare

to all socio economic segments

Godly

Compassion

By 2017..

• Beds

4,800 to 10,000

• Patients per annum

2 million to 15 million

• Hospitals

(7)

The Journey

1996

–

2006: Learning Phase

2007

–

2010: Consolidation Phase

2011 to Date: Expansion Phase

1996

SH Lippo Village

2002

2011

2012

2013

2014

2015

Kebon Jeruk

SH

SH Makassar

SH Palembang

SH Cinere

SHLV

–

Indonesia’s First Hospital to be

Accredited and Re-accredited by JCI

(2007, 2010 and 2014)

2013

–

The Company

successfully completed IPO

BIMC Nusa Dua

–

Indonesia’s First

Hospital to be Accredited by ACHS

Australia (2014)

(8)

8

The Operations

Public Expose

Unrivalled network across Indonesia

JCI

Sumatra Population : 50.6 mio

Kalimantan Population : 13.8 mio

Java Population : 136.6 mio

Sulawesi Population : 17.4 mio

Papua Population : 3.6 mio

Bali Population : 3.9 mio

Nusa Tenggara Population : 9.2 mio

Maluku Population : 2.6 mio

Jakarta Population : 10 mio

Greater Jakarta Population : 28 mio

ACHSI

Operational Hospitals (20)

Completed Hospital Awaiting for Operational License (2)*

Future Developments (44)

(9)

A Day At Siloam

400

Inpatient

Admissions

5,299

Outpatient

Visits

11

Cardiac

Procedures

146

Dialysis

Procedures

6 Neuro

Surgeries

2 Cardiac

Surgeries

22

Deliveries

11,241

Laboratory

Tests

570

Emergency

Visits

(10)

Premier Private Hospital Group

Mature Hospitals

11 Developing Hospitals

12 New Hospitals

13 Distinct Market Segment Hospitals

14 Completed Hospital In Yogyakarta

15

(11)

Mature Hospitals

BEKASI (East of Jakarta)

SILOAM HOSPITALS CIKARANG

114 Bed Capacity 108 Operational Beds 95 GP and Specialists 166 Nurses

Centre of Excellence : Occupational Health & Emergency

79.61% Ownership

EAST KALIMANTAN

232 Bed Capacity 165 Operational Bed 105 GP and Specialists 155 Nurses

Centre of Excellence : Orthopedics & Emergency

SILOAM HOSPITALS BALIKPAPAN

SOUTH JAKARTA

MRCCC SILOAM SEMANGGI

Centre of Excellence : Cancer, Liver & Emergency

TANGERANG (West of Jakarta)

SILOAM HOSPITALS LIPPO VILLAGE

JCIA

Centre of Excellence : Cardiology, Neuroscience, Orthopedics & Emergency

WEST JAKARTA

SILOAM HOSPITALS KEBON JERUK

Centre of Excellence : Urology, Orthopaedic, Cardiology & Emergency

EAST JAVA

SILOAM HOSPITALS SURABAYA

Centre of Excellence : Fertility Treatment, Cardiology & Emergency

79.84% Ownership

EAST SUMATERA

SILOAM HOSPITALS JAMBI

Centre of Excellence : Emergency

(12)

12

NORTH SULAWESI

SILOAM HOSPITALS MANADO

Developing Hospitals

Public Expose

SOUTH SULAWESI

SILOAM HOSPITALS MAKASSAR

Centre of Excellence : Cardiology, Endocrinology & Emergency

SOUTH SUMATERA

SILOAM HOSPITALS PALEMBANG

Centre of Excellence : Gastroenterology & Emergency

70.00% Ownership

BALI

SILOAM HOSPITALS BALI

Centre of Excellence : Treatment for tourists, Orthopedics, Cardiology & Emergency

SOUTH JAKARTA

SILOAM HOSPITALS TB SIMATUPANG

(13)

New Hospitals

WEST JAVA

SILOAM HOSPITALS PURWAKARTA

EAST NUSA TENGGARA

SILOAM HOSPITALS KUPANG

NORTH SUMATERA

SILOAM HOSPITALS MEDAN

Centre of Excellence : Emergency & Trauma

(14)

14

TANGERANG (West of Jakarta)

SILOAM GENERAL HOSPITAL (RSUS)

Distinct Market Segment Hospitals

Public Expose

SOUTH JAKARTA

SILOAM HOSPITALS ASRI

Centre of Excellence : Urology

DEPOK (South of Jakarta)

SILOAM HOSPITALS CINERE

Centre of Excellence: Cardiology

80.0% Ownership

BALI

BIMC KUTA

Centre of Excellence : Treatment for tourists & Emergency

BALI

BIMC NUSA DUA

(15)

Completed Hospital In Yogyakarta

(in April 2015 awaiting license to operate)

FAÇADE MAIN LOBBY

(16)

16

Siloam Clinic

Public Expose

CYBER PARK KARAWACI

There are other 15 Siloam Clinics in operation

MERTANADI BALI

FAÇADE RECEPTION GP’s CONSULTATION ROOM

(17)

For Completion In 2016

18 –

20 For Completion In 2017

21 –

22 Siloam Medika Under Development

23

(18)

18

BAU-BAU

BANGKA BELITUNG

For Completion In 2016

Public Expose

BOGOR

9M2015

Current

(19)

LABUAN BAJO*

JEMBER

For Completion In 2016

LUBUK LINGGAU

9M2015

Current

(20)

20

SORONG

For Completion In 2016

Public Expose

(21)

BANDUNG

AMBON

For Completion In 2017

CEMPAKA PUTIH

9M2015

Current

(22)

22

SEMARANG

SRONDOL

PANAKUKANG

MAKASSAR

For Completion In 2017

Public Expose

9M2015

Current

(23)

Siloam Medika Under Development

(completion in 2016)

BLU PLAZA BEKASI

KUNINGAN TOWER

BANJARMASIN PLUIT VILLAGE

LIPPO MALL BATU

NINE RESIDENCE

SURABAYA CITO

SEMARANG GAJAH MADA PLAZA

BEKASI GRAND MALL GUNUNG SAHARI

KALIMALANG

(24)

24

Capacity Expansion of Existing Hospitals

Public Expose

SILOAM HOSPITALS LIPPO VILLAGE

5th_{Floor OPD Extension}–_{Operational in December 2015}

MRCCC SILOAM SEMANGGI

120 New Beds – Completion Q1 2016

9M2015 Current

Current 9M2015

(25)

Strong Financial Performance

26 Patient Visits & Admissions

27 –

28 Awards

29 Nationwide Ambulance Call Centre

30

(26)

26

Strong Financial Performance

Public Expose

Note:

EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net). Siloam is the clear leader and fastest growing private hospital group in Indonesia serving all segments of the population

1,259

1,788

2,504

3,341

4,144

2011 2012 2013 2014 2015

155

221

298

466

574

2011 2012 2013 2014 2015

(27)

251,169

≥ 5 Beds 200-249 Beds 120-199 Beds <120 Beds ≥ Beds 120-199 Beds <120 Beds ≥ Beds <100 Beds Distinct Market

Patient Visits & Admissions

OPD Visits (+25%)

Mature Developing New

-8

(28)

28

Patient Visits & Admissions

Public Expose

IPD Admissions (+27%)

Average Length Of Stay (3.9)

17,681

≥ 5 Beds 200-249 Beds 120-199 Beds <120 Beds ≥ Beds 120-199 Beds <120 Beds ≥ Beds <100 Beds Distinct Market Segment

2014 2015

No of IPD Admissions

0%

Mature Developing New

(29)

Awards

Frost & Sullivan

2015 Indonesia Best Practices Awards : Indonesia Healthcare Services Provider of the Year

Brand Finance Brand Rating

Ranked 74th in Most Valuable Indonesian Brands 2015 & has been awarded a US$ 31 million

Brand Value & A+

SWA

Indonesia Healthcare Most Reputable Brand 2015 based on Healthcare Survey in Jabodetabek

City category Private Hospital

SWA

Indonesia Healthcare Most Reputable Brand 2015 based on

Healthcare Survey in Makassar City category Private Hospital

MarkPlus

Silver Champion of Indonesia WOW Service Excellence Award 2015 (Category: General Hospital

(A-Class), Region: Jawa Bali)

MarkPlus

Gold Champion of Indonesia WOW Service Excellence Award 2015 (Category: General Hospital

(B-Class), Region: Kalimantan)

MarkPlus

The Best Champion of Balikpapan WOW Service Excellence Award 2015 (Category: General Hospital

(B-Class))

MarkPlus

The Best of Indonesia WOW Service Excellence Award 2015 (Category: General Hospital

(30)

30

One Nationwide Ambulance Call Centre

(31)

Appointment Call Centre

(32)